hämostaseologie
130090;130265;140300
DE
EN
Home
Products
Journals
Books
Book Series
Service
Library Service
Help
Contact
Portal
Hämostaseologie
Full-text search
Full-text search
Author Search
Title Search
DOI Search
Metadata Search
Journal
Aims and Scope
Editorial Board
German National License
Authors
Instructions for Authors
Submit a Manuscript
Subscription
Subscription Information & Contacts
Institutional Licensing
Collections
HAMO Women
About Women in Medicine
Open Access
GTH
GTH News
Not Logged In
Login
Username or e-mail address:
Password:
Forgot Access Data?
Register Now
OpenAthens/Shibboleth Login
Shopping Cart
Year (Archive)
2024
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
1982
1981
Issues
Current Issue
Free Sample Issue (01/2024)
Related Journals
Thrombosis and Haemostasis
International Journal of Angiology
Seminars in Thrombosis and Hemostasis
The Thoracic and Cardiovascular Surgeon
The Thoracic and Cardiovascular Surgeon Reports
TH Open
Abstracts (HTML)
List of Authors
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
Y
Z
Ú
Ć
Š
Obser, T
Characterization of activity and cleavage of von Willebrand disease type 2B variants
Oldenburg, J
Real-world experience on the use of rIX-FP in patients with haemophilia B: Interim results from a prospective, non-interventional, post-market surveillance study in Germany
Thrombophilic Phaenotype in a Family with High Frequency of Homozygous Antithrombin Deficiency Typ IIb Budapest 3 and Mild Factor VII Deficiency due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment
Aptamer-based ex vivo monitoring of thrombin and activated protein C generation on blood outgrowth endothelial cells for individualized assessment of the protein C pathway
Oleshko, O
von Willebrand factor (vWF) significantly modifies the sedimentation profile of FVIII-containing immune complexes (FVIII-IC) based on the type of anti-FVIII antibodies
Olive, D
Evolution of platelet phenotype during SARS-CoV-2 infection
Olivieri, M
Real-world experience on the use of rIX-FP in patients with haemophilia B: Interim results from a prospective, non-interventional, post-market surveillance study in Germany
Newly diagnosed children and adolescents with haemophilia A and B in Germany – the GEPHARD study of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research
A retrospective patient chart review of real-world clinical outcomes and prophylactic factor VIII consumption in Italian patients with haemophilia A switching to extended dosing intervals with rVIII SingleChain
A comparison of prophylaxis dosing frequency and associated clinical outcomes between rVIII-SingleChain and other rFVIII products commonly used in Italian patients with haemophilia A
Orlandi, S
Platelet Distribution Width as a marker of platelet reactivity and platelet activation status in men and women of the Moli-family cohort
Oseev, A
Assessment of primary hemostasis with an acoustic biosensor using shear dependent kinetics behavior: principle and limitations
Osswald, S
Red Cell Omega-3 FA Correlate with Reduced DDimer and Beta-Thromboglobulin as Markers of Coagulation Activation in Atrial Fibrillation
Ott, HW
A novel approach to laboratory assessment of platelet von Willebrand factor
Otto, O
Low adhesion and interaction forces of Myh9 mutant platelets lead to impaired clot retraction and unstable thrombus formation
Platelets from patients with MYH9 related disorders are mechanically stiffer
Ozelo, M
Second interim analysis results from the STASEY trial: A single-arm, multicentre, open-label, phase III clinical trial to evaluate the safety and tolerability of emicizumab prophylaxis in persons with haemophilia A (PwHA) with FVIII inhibitors